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Essentials
• Life-threatening maternofetal thrombocytopenias mostly depend on a IIb b 3 antigens.
• We performed serological, genomic and in vitro studies of two life-threatening thrombocytopenias.
• Identification of a c.368C>T variation leading to Pro123Leu substitution in GPIX.
• A rare GPIX variant reported in a genomic database define a new alloantigen.
Summary. Background: After three miscarriages, a 39-yearold woman gave birth, with a 1-year interval, to two severely thrombocytopenic neonates (4 910 ) with intracranial hemorrhages. Transfusion of platelet concentrates corrected the thrombocytopenia. The outcome was favorable for the first child, but the second one died 10 days after cesarean delivery (31 weeks of gestation + 6 days). Methods: Serologic studies were performed with mAb-specific immobilization of platelet antigens and flow cytometry techniques. Human platelet alloantigen (HPA) genotyping was performed with the BioArray HPA BeadChip and PCR-sequence-specific primer techniques. Genomic DNA was studied by direct sequencing of PCR products. The mutant glycoprotein (GP) was expressed in transiently transfected HEK293 cells. Results: In MAIPA assay, the maternal serum faintly reacted with GPIbIX from paternal and child 1 platelets, but not with maternal or panel platelets. No maternofetal incompatibility was found in the 22 known HPA systems, tested except for HPA-1b in child 2. A new alloantigen carried by GPIbIX was suspected. Genomic sequencing revealed a paternal GPIX variation (NM_000174.4: c.368C>T). The father and children were heterozygous and incompatible with the mother, who was NM_000174.4: c.368C homozygous. The maternal serum reacted with the GPIX NP_000165.1:p.Leu123 form coexpressed with GPIb in transfected HEK293 cells. The NM_000174.4:c.368T allele (rs202229101) has a minor allele frequency of 0.0002, and was not detected in 120 French subjects (families with fetal and neonatal alloimmune thrombocytopenia [FNAIT] ), suggesting that it is rarely implicated in alloimmunization. Conclusion: The NP_000165.1:p.Leu123 allele named Cab4b is the first platelet alloantigen described on GPIX. In the absence of other known maternofetal incom
Introduction
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is characterized by fetal and neonatal platelet destruction mediated by maternal alloantibodies specific to incompatible alloantigens inherited from the father. The incidence of FNAIT has been shown to be 1 per 800-1000 live births [1] , and the most feared complications are intracranial hemorrhages (ICHs) leading to death or neurologic sequelae [2] . To date, 29 human platelet alloantigens (HPAs) have been described (see http://www.ebi.ac.uk/ipd/hpa/ for an up-to-date list). They result from gene polymorphisms mainly involving integrin a IIb b 3 (or glycoprotein [GP] IIbIIIa). Only two, HPA-2 and HPA-12, are located on the platelet membrane GPIbIX. The HPA-2 system results from the NM_000173.6:c.482C>T polymorphism in the GPIba gene [3] , and the HPA-12 system from the NM_000407.4: c.119G>A polymorphism in the GPIbb gene [4] . GPIba and GPIbb are the two subunits (stoichiometry 1 : 2) of GPIb that non-covalently associate with GPIX to form the GPIbIX complex [5] . This complex is coexpressed with GPV at the surfaces of non-activated platelets, and mediates their adhesion to the subendothelium by interacting with von Willebrand factor in condition of high shear stress [6] . It can also bind thrombin to participate in a thrombin-dependent platelet activation process [7] .
In a context of two severe consecutive FNAITs in a Caucasian family, we describe, for the first time, a new platelet alloantigen located on GPIX and named Cab4b.
Materials and methods

Case report
After three miscarriages, a 39-year-old Caucasian woman gave birth, with a 1-year interval, to two severely thrombocytopenic neonates. Cranial ultrasound scans revealed cerebral hemorrhages after birth for the first child and at 31 weeks of gestation (WG) for the second one. The first thrombocytopenic (4 9 10 9 L -1 ) neonate (child 1) was delivered by cesarean section at 37 WG (for clinical details, see Table S1 ). His platelet count was normalized with one apheresis platelet concentrate (APC), and his outcome was favorable without neurologic sequelae. The second neonate (child 2) was delivered by emergency cesarean section at 31 WG, 6 days after the diagnosis of an ICH with diminution of fetal movements. The neonate presented with thrombocytopenia (33 9 10 9 L -1 ), hydrocephaly, and ischemic lesions revealed by magnetic resonance imaging (MRI). Transfusion of APC raised the platelet count to 396 9 10 9 L -1 , but the infant died at 10 days after birth. Blood samples from the mother and father were sent to our laboratory for FNAIT diagnosis after the death of child 2. Figure 1 shows the MRI results revealing large ICHs in both children.
Blood samples
Blood samples from the parents, child 1, child 2 and blood donors collected by venipuncture samples in 5 mM EDTA as anticoagulant and without anticoagulant were sent to our laboratory. Platelets were separated by differential centrifugation (Platelet rich plasma: 200 9 g, 10 min; Washed platelets: 2050 9 g, 10 min), and stored until use at 4°C in isotonic solution containing 0.1% sodium azide. Written informed consent was obtained from all subjects or their legal representatives with approval of the institutional ethics committee, in accordance with the Declaration of Helsinki.
Platelet serology
Platelet phenotyping and characterization of maternal serum alloantibody were performed with the mAb-specific immobilization of platelet antigens (MAIPA) technique [8] .
mAbs
The following mAbs were used: Gi9 (Beckman Coulter, Roissy, France) against GPIaIIa; Pl2-46 and Pl1-64 against a IIb ; Gi5 (Coger, Paris, France) against a IIb b 3 ; GRP (Dr Garrido, Granada, Spain) against GPIbIX; SZ2 against GPIba and SZ1 against GPIX (Beckman Coulter); and MB45 against GPIba (Sanquin, Amsterdam, the Netherlands).
Isolation of genomic DNA
Genomic DNA was isolated from peripheral blood with MagNA Pure Compact Isolation Nucleic Acid Kit 1 and the MagNA Pure extraction system according to the manufacturer's instructions (Roche Diagnostics, Mannheim, Germany).
Genotyping
HPA-1 to HPA-9, HPA-11 and HPA-15 genotyping was performed with the BioArray HPA BeadChip system (Immucor, Warren, NJ, USA). HPA-10, HPA-12 to HPA-21 and HPA-23 to HPA-28 genotyping was performed with in-house PCR-sequence-specific primer (SSP) techniques developed from published data [4, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] .
PCR and sequencing
Coding sequences of the GPIba, GPIbb, GPIX and GPV genes were amplified by PCR with primers (Table S2) Child 2 Child 1 defined according to the NCBI reference sequences for GPIba (code NG_008767.2), GPIbb (code NG_007974.1), GPIX (code NG_008715.1), and GPV (code Z23091.1). These specific genomic forward and reverse primers contain, respectively, the common sequences 5 0 p-cgccagaattctcagtcacg-3 0 OH and 5 0 p-ccagccagatatcagctatg-3 0 OH. For nucleotide numbering, the adenine nucleotide of the formyl-methionine codon ATG was designated + 1 (cDNA GPIX NCBI code NM_000174.4). For amino acid numbering, the first amino acid of GPIX precursor was designated + 1. All GPIba, GPIbb, GPIX and GPV sequencing fragments were amplified with 4 lL of DNA extract in a buffer containing 200 mmol L À1 dNTP, 1. 
SSP primer amplification
The NM_000173.6:c.368T>C mutation was genotyped by PCR-SSP. Briefly, PCR was performed with 50 ng of DNA in 20 lL of a reaction mix containing 1 9 Taq buffer, 2 mM MgCl 2 , 200 mM each dNTP and 0.5 units of Ampli Taq Gold DNA polymerase (Perkin-Elmer, Courtaboeuf, France), 5% DMSO, 1.2 mM common forward primer 5 0 pggaggaccgcacgcccgagg-3 0 OH, and 1.2 mM reverse primer 5 0 p-gcctgtcagccggcccagcg-3 0 OH to amplify the Cab4a allele, or 5 0 p-gcctgtcagccggcccagca-3 0 OH to amplify the Cab4b allele. The reaction mix also contained 7 lM each of internal positive control primers CRP-I 5 0 p-ccagcctctctcatgcttttggccagacag-3 0 OH and CRP-II 5 0 p-gggtcgaggacagttccgtgtagaagtgga-3 0 OH. PCR was performed in a MasterCycler ep Gradiant S thermocycler (Eppendorf, Le Pecq, France). A single step of 95°C for 2 min to denature genomic DNA was followed by 29 cycles of denaturation (95°C, 20 s), annealing (70°C, 20 s), and elongation (72°C, 45 s). A final elongation step (72°C, 7 min) ended the reaction. PCR products were analyzed under ultraviolet light in the presence of ethidium bromide after electrophoresis in a 2.5% agarose gel.
Site-directed mutagenesis
The Cab4b mutation was introduced into WT GPIX cDNA (from S. Santoso, Institute for Clinical Immunology and Transfusion Medicine, Giessen, Germany) cloned in the eukaryotic expression vector pcDNA3 by use of the Quick Change XL II Site-directed mutagenesis kit (Agilent Technologies, Les Ulis, France), according to the manufacturer's instructions. The mutagenic oligonucleotides were 5 0 -tgcccatggcctgctgggccggc-3 0 and 5 0 -gccggcccagcaggccatgg gca-3 0 . The presence of the mutation was confirmed by direct sequencing.
Cell culture, transfection, and cloning HEK293 cells (American Type Culture Collection, Rockville, MD, USA) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 1% antimycotic/antibiotic reagent (Invitrogen, CergyPontoise, France) in a 5% CO 2 saturating-humidity atmosphere. HEK293 cells were transiently transfected according to previously published procedures [12] . HEK293 cells were harvested with the trypsin-EDTA method, and washed three times in phosphate-buffered saline (PBS) containing 1% (w/v) bovine serum albumin (BSA) before use.
Flow cytometry
The reactivity of maternal serum with HEK293 cells expressing GPIX-Pro123 or mutant GPIX-Leu123 forms of GPIbIX was analyzed by flow cytometry. Fifty microliters of the washed HEK293 cell (5 9 10 5 ) suspension was mixed with 50 lL of serum, and incubated for 1 h at 4°C with gentle rocking. After three washes with 2 mL of PBS containing 0.5% (w/v) BSA (PBS-BSA), cells were suspended in 100 lL of PBS-BSA containing 2 lL of R-phycoerythrin-conjugated goat anti-human IgGs (Fc-specific) (Jackson ImmunoResearch Europe, Newmarket, UK) and 10 lL of fluorescein isothiocyanate-conjugated mAb SZ-1. Cells were incubated for 1 h at 4°C under gentle rocking, washed three times, and suspended in 1 mL of PBS-BSA containing 10 lg mL À1 7-aminoactinomycin D (7-AAD) (Thermo Fisher Scientific, Courtaboeuf, France). Bound human IgGs were detected at the surfaces of cells negative for 7-AAD labeling and positive for SZ-1 labeling by use of an Epics-XL flow cytometer (Beckman Coulter).
mAb-specific immobilization of HEK293 cell antigens assay
The reactivity of the maternal serum with the transfected HEK293 cells was tested by use of a mAb-specific immobilization of cell antigens (MAICA) technique derived from mAb-specific immobilization of granulocyte antigens as described by Bux et al. [23] . The mAbs GRP, MB45, SZ1 and SZ2 were used to capture the GPIbIX complex.
Interclass comparison of GPIX sequences
The amino acid sequence of the mature GPIX referenced as AAH30229.1 in GenBank was used to select homologous sequences from non-redundant protein sequence databases by use of the PSI-BLAST online tool. Sequences with < 45% coverage were discarded. In selected sequences, the maximum observed E-value was 1.00 9 10 -8
. Furthermore, non-GPIX or GPIX-like sequences, hypothetical sequences, isoforms and sequences annotated as 'low-quality sequences' were also discarded. Finally, duplicated sequences for single species were not taken into account. Sequences were aligned by use of the protein multiple sequence alignments tool CLUSTAL OMEGA (http://www.eb i.ac.uk/Tools/msa/clustalo/) [24] . From these alignments, a few more were discarded because of large gaps/inserts. Among the 500 sequences initially retrieved from GenBank, only 173 were conserved. Curated alignments from CLUSTAL OMEGA were used with SKYLIGN (http://skylign.org/) [25] to perform statistical analyses and WEBLOGO cartoon editing. PSI-BLAST sequence selection, alignment and statistical analyses were performed on December 2016.
Results
Serologic study
For FNAIT diagnostic purposes, the reactivity of the maternal serum was tested against a panel of platelet donors and paternal and maternal platelet by MAIPA. Figure 2 shows the results obtained for GPIbIX. Faint reactivity was observed with paternal platelets, but not with the panel or with maternal platelets. Maternal serum also reacted with child 1 platelets. This reactivity was confirmed by use of the mAbs GRP, SZ1, SZ2 and MB45 against GPIbIX (Fig. S1) . No reactivity was observed with the GPIaIIa or GPIIbIIIa complexes currently studied in routine diagnoses (data not shown). An autoantibody against GPIIbIIIa and adsorbed onto paternal platelet surfaces was detected, but no autoantibodies against against GPIaIIa and GPIbIX were detected (data not shown). This anti-GPIIbIIIa paternal autoimmunity did not concern the studied FNAIT and its diagnosis. These results suggested the presence of a maternal antibody against GPIbIX carried by the paternal and child 1 platelets. Child 2 platelets were not available for testing.
Genotypic analysis
All family members were routinely genotyped in systems HPA-1, HPA-2, HPA-3, HPA-4, HPA-5, HPA-6, HPA-7, HPA-8, HPA-9, HPA-11 and HPA-15 by the use of Bioarray BeadChip technology. A single maternofetal incompatibility between the mother and child 2 was detected in the HPA-1 system. The mother was HPA-1a homozygous, whereas the father and child 2 were HPA1a/b. We subsequently gained access to child 1 blood samples, and child 1 was HPA-1a homozygous and thus compatible with his mother. With regard to the severity of the children's thrombocytopenias, other known HPA alloantigens, i.e. HPA-10 to HPA-14, HPA-16 to HPA-21, HPA-24, and HPA-27, were also studied, without any additional incompatibility being identified.
As the HPA-2 system and HPA-12bw alloantigen carried by the GPIbIX complex were not involved in maternal serum reactivity, the coding sequences of GPIba, GPIbb, GPIX and GPV paternal genes were investigated. A single NM_000174.4:c.368C>T variation reported in the dbSNP database of the NCBI (rs202229101) was identified in the paternal GPIX gene (Fig. 3A) . To confirm the presence of NM_000174.4:c.368C>T polymorphism, a PCR-SSP was set-up (Fig. 3B) . The father and the two children were heterozygous and incompatible with the mother, who was NM_000174.4:c.368C homozygous. A control DNA was genotyped NM_000174.4:c.368C Identification of a maternal antibody specifically directed against glycoprotein (GP) IbIX carried by the father's platelets. A GRP mAb was used to capture GPIbIX, and the reactivity of the maternal serum was tested by the mAb-specific immobilization of platelet antigens (MAIPA) technique with a pool of group O platelets (Panel) and platelets from the mother, father, and child 1. An in-house MAIPA technique was used to study maternal serum reactivity with panel and maternal platelets, whereas the apDia MAIPA technique was used for paternal and child 1 platelets. The dashed line indicates the positive threshold (OD = 0.250) used in our inhouse MAIPA technique, and the dotted line indicates the cut-off of the apDia MAIPA technique (OD = 0.200). As maternal serum did not react with platelets from the panel or the mother, it was specifically positive for GPIbIX carried by paternal and child 1 platelets. The difference in reactivity observed between paternal and child 1 platelets probably resulted from a difference in platelet numbers used in the test. These results are representative of several independent experiments with each platelet tested.
homozygous. PCR-SSP results for child 1 and child 2 were confirmed by sequencing (data not shown).
The frequency of the NM_000174.4:c.368T allele was estimated by PCR-SSP in a population of 120 unrelated French parents (mothers and fathers) studied for FNAIT diagnosis (data not shown). Among these 120 genotyped subjects, none with the Cab4b allele were detected. This is in agreement with the frequency of this polymorphism (rs202229101), which is reported to be under 1/5000 in the 1000 Genome Project data.
Characterization of a new platelet alloantigen Cab4b
The NM_000174.4:c.368C>T variation leads to a Pro123-Leu substitution in the GPIX precursor (NP_000165.1: p.Pro123Leu) corresponding to a Pro123Leu substitution in mature GPIX. To study the antigenicity of the GPIXLeu107 form of GPIbIX, both WT and mutated complexes were transiently expressed in HEK293 cells. Figure 4 shows that the GPIX-Leu107 form of GPIbIX was expressed at the surfaces of transfected HEK293 cells at a level very close to that of the WT GPIX-Pro107 form (mean fluorescence intensities of 6.6 and 3.6, respectively). The Pro107Leu substitution in GPIX did not significantly affect the expression of GPIbIX. The reactivity of maternal serum with transfected cells was then tested by flow cytometry (Fig. 5A) . The maternal serum specifically reacted with cells expressing the GPIX-Leu107 form of GPIbIX (bold line), but not with cells expressing the GPIX-Pro107 form (dashed line) of GPIbIX or with nontransfected cells (dotted line). For the three cell types, the major peak correspond to cells not reacting with the maternal serum (untransfected or transfected with the WT GPIX-Pro107 form of GPIbIX).
To confirm the specificity of the reactivity observed, non-transfected and GPIbIX-transfected HEK293 cells were incubated with maternal serum and used in a MAICA test (Fig. 5B) . Cells expressing the Cab4b form of GPIbIX reacted positively with the maternal serum, whereas non-transfected cells and cells expressing the Cab4a form of GPIbIX did not.
Discussion
We report here the characterization of a new platelet alloantigen responsible for severe neonatal thrombocytopenia and life-threatening ICH in two neonates. MAIPA showed maternal serum reacting selectively with paternal GPIbIX, suggesting an alloimmune response to a rare antigen. Sequencing analysis of paternal GPIba, GPIbb, GPIX and GPV genes revealed a single heterozygous NM_000174.4:c.368C>T variation in the GPIX gene leading to a proline to leucine substitution at position 107 of mature GPIX or at position 123 of its precursor (NP_000165.1:p.Pro123Leu). Both sequencing and PCR-SSP analyses revealed that the two neonates were heterozygous c.368C/T, like their father, and incompatible with their mother, who was homozygous for allele c.368C. Both flow cytometry and MAICA analysis results showed that only HEK293 cells expressing the GPIX-Leu107 form of GPIbIX could react with the maternal serum. These results indicated that the Leu107 form of GPIX defines a new platelet alloantigen, which has been named Cab4b. NM_000174.4c.368T (accession number rs202229101) is rare, as reported in the NCBI dbSNP database, with a minor allele frequency (MAF) of 0.0002 estimated from large genome studies (last accessed December 2016). This low MAF could explain why it was not found in our cohort of 120 French subjects. These data suggest that the Cab4b polymorphism will rarely be responsible for FNAIT.
To analyze amino acid polymorphism at position 107 of mature GPIX in an evolutionary context, homologous sequences were searched by use of the PSI-BLAST alignment tool. Of 173 sequences retained, 75 were from mammals, 57 from birds, six from reptiles, one from batrachians, and 34 from fish. Pro107 of mature GPIX was mostly conserved (82.7% of occurrences) in mammals (Fig. S3) , although alanine, serine, threonine and leucine were also found. Leucine at position 107 was seen in GPIX of a common marmoset (sequence XP_002758721.1 in Fig. S2 ). Considering sequences from other classes, Pro107 was also encountered in birds, reptiles, and fish, but, as in mammals, other amino acids were also encountered at this position (Fig. S3A,B) . Except for a few positions (Pro100, Leu111, Gln110, and Gly113), positions 100-114 showed high variability in amino acids (Fig. S3) . Interestingly, none of the 13 missense variations located between amino acids 112 and 133 and reported in the dbSNP database (last accessed December 2016) was considered as pathogenic (Table S3) . Hence, this region of GPIX appeared to be polymorphic. To the best of our knowledge, only three missense variations in the GPIX sequence have been reported to be related to defective expression of GPIbIX in Bernard-Soulier syndrome (Table S3) [26, 27] . However, these mutations affected Tyr79, Cys97, and Cys119 (mature GPIX), which were 100% conserved in mammals, birds, and reptiles, and 99% conserved in fish. As only variations affecting 100% conserved residues were related to defects in GPIbIX expression, and Pro107 is located in a region with high residue variability, this suggested that the Pro107Leu substitution should not significantly affect GPIbIX expression. These data are concordant with our results showing that transfected HEK293 cells expressed GPIX-Leu107 at their surfaces similarly to WT GPIX-Pro107. Furthermore, MAIPA analyses using both platelets and transfected HEK293 cells and performed with the anti-GPIba mAb GRP showed that GPIX-Leu107 and GPIba ), which were probably responsible for the observed ICH, and it was shown that anti-Cab4b alloantibodies reacted strongly with GPIbIX of child 1 platelets. Thus, alloantibodies against Cab4b antigens might induce very severe and life-threatening thrombocytopenias. The case of child 1 is in support of this hypothesis, as he was compatible with his mother in all known HPA systems except for Cab4b alloantigen. For child 2, an HPA-1b maternofetal incompatibility was documented, but without any anti-HPA-1b alloantibodies being detected in the maternal serum. Despite having less severe thrombocytopenia (33 9 10 9 L -1 ) than her brother and a platelet count corrected up to 396 9 10 9 L -1 by APC transfusion, she died 10 days after birth. An association between anti-HPA-1b and anti-Cab4b alloantibodies can be suspected to have worsened the thrombocytopenia effect, and to have led to hydrocephaly and ischemic lesions that were not observed in her brother. As the platelet counts of both children were corrected by platelet transfusions, the fatal outcome of child 2 probably resulted from the severity of irreversible damage that occurred during pregnancy. Large cohort studies have reported on very few cases of FNAIT caused by GPIbIX alloantibodies [28] [29] [30] [31] [32] . Apart from the difficulty in detecting them, anti-GPIbIX alloantibodies are suspected to cause miscarriages, lowering the number of identified FNAIT cases that are dependent on anti-GPIbIX alloantibodies [33] . Our results suggest that Cab4 alloantibodies induced very severe ICH (Fig. 1) . Like Cab4b, anti-HPA-2 and anti-HPA-12bw alloantibodies can also lead to major thrombocytopenias and ICH [28, [34] [35] [36] . ICH in FNAIT is mainly associated with anti-HPA-1a alloimmunization, where antibodies against the b 3 integrin subunit react with the a v b 3 vitronectin receptor expressed by fetal endothelial cells (ECs). A murine model suggested that ICH may mainly result from impaired angiogenesis in response to anti-b 3 reactivity [37] . Furthermore, Santoso et al. showed that only anti-b 3 antibodies that are able to react with a v b 3 integrin are associated with ICH by activating EC apoptosis [38] . It should be noted that anti-HPA-3 alloantibodies can induce ICH, although a IIb is not expressed by ECs [39] . GPIbIX expression in fetal ECs has not yet been reported, although the complex may be present in ECs from adults [40] . Finally, some anti-GPIbIX antibodies could activate platelets [41] , inducing GPIbIX desialylation and Fc-independent platelet clearance [42] . The ability of Cab4b to activate platelets or to alter platelet function remains to be studied. However, Tiller et al. reported that, in their series, ICH was significantly associated with major thrombocytopenias [32] . Thus, the severity of the thrombocytopenias (4 9 10 9 L -1 and 33 9 10 9 L -1 ) induced by Cab4b antibody might explain the observed ICHs.
To summarize, in a context of two very severe neonatal thrombocytopenias, we have characterized a new low-frequency platelet alloantigen, Cab4b, and the first to be expressed on GPIX. The NM_000174.4:c.368C>T variation resulted in a p.Pro107Leu polymorphism in mature GPIX. In vitro studies with HEK293 cells transiently expressing the mutant form of the GPIbIX complex allowed the identification of the GPIX-Leu107 form of GPIbIX to be responsible for maternofetal alloimmunization and very severe thrombocytopenias. It remains to be determined, in future studies, whether the ICH is only the consequence of the profound thrombocytopenia or an effect of the antibodies on platelet function and ECs. The three cell types were incubated with the mother's serum and mAb GRP. After lysis, GPIbIX was captured in microplate wells by mAb GRP, and bound human IgG was detected with a goat antihuman IgG conjugated to peroxidase. OD was measured to follow a colorimetric reaction. Maternal serum contained an antibody specifically directed against Cab4b GPIbIX. Reactivity was observed neither with non-transfected cells nor with cells expressing Cab4a GPIbIX. Shown is mean OD (AE standard deviation) of three independent experiments. MFI, mean fluorescence intensity; NT, untransfected cells.
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